Xavier Jouven
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Xavier Jouven has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Alain Cariou
Cochin University Hospital (AP-HP) and University Paris Cité (Medical School), Paris, France
1 shared publication Alexandre Loupy
Université de Paris, Paris Cardiovascular Research Center (PARCC), Paris Translational Research Center for Organ Transplantation, INSERM , UMR-S970, 75015 Paris , France
1 shared publication- Anouk Asselin
Université de Paris, Paris Cardiovascular Research Center (PARCC), Paris Translational Research Center for Organ Transplantation, INSERM , UMR-S970, 75015 Paris , France
1 shared publication - Daniel Jost
Paris Fire Brigade
1 shared publication Eloi Marijon
Paris Sudden Death Expertise Center, Paris, France; Paris Cardiovascular Research Center (PARCC), INSERM Unit 970, Paris, France; AP-HP, Cardiology Department, Hôpital Européen Georges Pompidou, Paris, France; Paris Descartes University, Paris, France
1 shared publication- Eloi Marijon
Université Paris-Descartes, Hôpital Européen Georges Pompidou, Département de Cardiologie, Paris
1 shared publication
Latest Publications
- Open Access
- 19 May 2023
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 25 (5)
Sudden cardiac death after heart transplantation: a population-based study
The epidemiology of sudden cardiac death (SCD) after heart transplantation (HTx) remains imprecisely described. We aimed to assess the incidence and determinants of SCD in a large cohort of HTx recipients, compared with the general population. Consecutive HTx recipients (n = 1246, 2 centres) transplanted between 2004 and 2016 were included. We prospectively assessed clinical, biological, pathologic, and functional parameters. SCD was centrally adjudicated. We compared the SCD incidence beyond the first year post-transplant in this cohort with that observed in the general population of the same geographic area (registry carried out by the same group of investigators; n = 19 706 SCD). We performed a competing risk multivariate Cox model to identify variables associated with SCD. The annual incidence of SCD was 12.5 per 1,000 person-years [95% confidence interval (CI), 9.7–15.9] in the HTx recipients cohort compared with 0.54 per 1,000 person-years (95% CI, 0.53–0.55) in the general population (P < 0.001). The risk of SCD was markedly elevated among the youngest HTx recipients with standardized mortality ratios for SCD up to 837 for recipients ≤30 years. Beyond the first year, SCD was the leading cause of death. Five variables were independently associated with SCD: older donor age (P = 0.003), younger recipient age (P = 0.001) and ethnicity (P = 0.034), pre-existing donor-specific antibodies (P = 0.009), and last left ventricular ejection fraction (P = 0.048). HTx recipients, particularly the youngest, were at very high risk of SCD compared with the general population. The consideration of specific risk factors may help identify high-risk subgroups.
- 19 May 2023
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 25 (5)
Open AccessSudden cardiac death after heart transplantation: a population-based study
The epidemiology of sudden cardiac death (SCD) after heart transplantation (HTx) remains imprecisely described. We aimed to assess the incidence and determinants of SCD in a large cohort of HTx recipients, compared with the general population. Consecutive HTx recipients (n = 1246, 2 centres) transplanted between 2004 and 2016 were included. We prospectively assessed clinical, biological, pathologic, and functional parameters. SCD was centrally adjudicated. We compared the SCD incidence beyond the first year post-transplant in this cohort with that observed in the general population of the same geographic area (registry carried out by the same group of investigators; n = 19 706 SCD). We performed a competing risk multivariate Cox model to identify variables associated with SCD. The annual incidence of SCD was 12.5 per 1,000 person-years [95% confidence interval (CI), 9.7–15.9] in the HTx recipients cohort compared with 0.54 per 1,000 person-years (95% CI, 0.53–0.55) in the general population (P < 0.001). The risk of SCD was markedly elevated among the youngest HTx recipients with standardized mortality ratios for SCD up to 837 for recipients ≤30 years. Beyond the first year, SCD was the leading cause of death. Five variables were independently associated with SCD: older donor age (P = 0.003), younger recipient age (P = 0.001) and ethnicity (P = 0.034), pre-existing donor-specific antibodies (P = 0.009), and last left ventricular ejection fraction (P = 0.048). HTx recipients, particularly the youngest, were at very high risk of SCD compared with the general population. The consideration of specific risk factors may help identify high-risk subgroups.
- 1 September 2017
- Published by Elsevier in Resuscitation
- Vol. 118, e72
Evolution of the survival of non-traumatic out-of-hospital cardiac arrests due to ventricular fibrillation over a 10 years period
- 1 September 2017
- Published by Elsevier in Resuscitation
- Vol. 118, e72
Evolution of the survival of non-traumatic out-of-hospital cardiac arrests due to ventricular fibrillation over a 10 years period
- 1 June 2017
- Published by Elsevier in International Journal of Cardiology
- Vol. 237, 10-12
Opening a new front in the fight against sudden cardiac death: Is it time for near-term prevention?
- 1 June 2017
- Published by Elsevier in International Journal of Cardiology
- Vol. 237, 10-12
Opening a new front in the fight against sudden cardiac death: Is it time for near-term prevention?